Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurora SpineASAPF +3.76%38 3-Year EPS without NRI Growth Rate is 22.70% as of Mar. 2026, which is 19% below its 10-year median of 27.95. GuruFocus rates ASAPF with a GF Score™ of 38/100 and a GF Value™ of $0.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 660 Medical Devices & Instruments companies, Aurora Spine ranks better than 69.24% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 22.70% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 0.50% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 15.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Aurora Spine was 76.90% per year. The lowest was -194.30% per year. And the median was 27.95% per year.
Aurora Spine (OTCPK:ASAPF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Aurora Spine 3-Year EPS without NRI Growth Rate Related Terms
ASAPF vs ABT, SYK, MDT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, Aurora Spine's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Aurora Spine's 3-Year EPS without NRI Growth Rate falls into.
Aurora Spine 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 22.70% mean?
Aurora Spine (ASAPF) has a 3-Year EPS without NRI Growth Rate of 22.70% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Aurora Spine and its competitors. This is 19% below median its historical median of 27.95. According to the industry distribution chart, Aurora Spine ranks #203 out of 660 companies in the Medical Devices & Instruments industry, placing it in the top 30.8%.
Is Aurora Spine's 3-Year EPS without NRI Growth Rate too high?
Aurora Spine's current 3-Year EPS without NRI Growth Rate of 22.70% is 19% below median its 10-year median of 27.95. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 8.25. Aurora Spine's value of 22.70% is 175.2% above this industry median. Based on the distribution chart, Aurora Spine ranks #203 out of 660 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aurora Spine has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's 3-Year EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #203 out of 660 companies for 3-Year EPS without NRI Growth Rate. This puts Aurora Spine in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 8.25. Aurora Spine's value of 22.70% is 175.2% above this benchmark. While the company's 10-year median is 27.95 vs. the industry median of 8.25, Aurora Spine has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.25, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Spine's current 3-Year EPS without NRI Growth Rate of 22.70% is 175.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current 3-Year EPS without NRI Growth Rate is 22.70%, which is 19% below median its own 10-year median of 27.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.15 — trading 35.2% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 22.70%, which is 19% below median its 10-year median of 27.95 and 175.2% above the Medical Devices & Instruments industry median of 8.25. Aurora Spine's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current 3-Year EPS without NRI Growth Rate is 22.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.15 is trading 35.2% below its estimated GF Value™ of $0.23.
GuruFocus considers Aurora Spine to be Possible Value Trap.
Key valuation signals for ASAPF:
3-Year EPS without NRI Growth Rate: 22.70% (19% below median its 10-year median of 27.95)
GF Value™: $0.23 vs. price of $0.15 (35.2% below fair value)
Industry Position: 175.2% above the Medical Devices & Instruments median (#203 of 660)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
38GF Score
Get the complete analysis for ASAPF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
